ABSTRACT
Approximately 60 million women use the intrauterine contraceptive devices [IUCD] worldwide. IUCD constitutes one of the most accepted and widely used methods of contraception especially in the developing countries. Several studies have demonstrated an increased risk of pelvic inflammatory disease [PID] in women using intrauterine contraceptive devices. The role of chlamydia trachomatis in causing PID among IUCD users is not clear. This prospective study aims to clarify the effect of copper T IUCD on the incidence of chlamydia trachomatis infection in the female genital tract. This was done by measuring anti-chlamydia antibodies in the serum of copper T IUCD users compared to non-users among 100 patients attending Family Planning Clinic in Ain Shams University Maternity Hospital. The results showed that Chlamydia antibodies were significantly higher [P < 0.01] among IUCD users compared to non-users. In addition, on linking diagnostic criteria of chlamydia trachomatis infection to the mean serology of chlamydial antibodies, there was no significant correlation to serology [P > 0.05]. This indicates the silent nature of this infection and the importance of screening of chlamydia trachomatis among women at riskor acquiring this infection